Loading...

Loading...

Medical Residency Surge: Balancing Quantity and Quality
By Mauricio Gonzalez Urquijo - Mon, 01/19/2026 - 08:00
Mexico’s medical residency expansion must prioritize training quality and governance to ensure long-term patient safety, writes Mauricio Gonzalez.
https://mexicobusiness.news/tag/patient-safety
More Health
Challenges, Opportunities of Interprofessional Health Training
By Jorge Eugenio Valdez García - Mon, 01/20/2025 - 14:00
Interprofessional education represents an important shift in the education of health professionals. Jorge Eugenio Valdez García explains why.
FDA Drafts Guidelines to Improve Pulse Oximeter Accuracy
By MBN Staff - Mon, 01/13/2025 - 11:20
FDA's new guidelines aim to enhance pulse oximeter accuracy by requiring diverse testing and clearer labeling to ensure equitable medical care.
FDA Clears Air Assist Device for Enhanced Colonoscopy Efficiency
By MBN Staff - Fri, 12/20/2024 - 14:45
Astro Concepts receives FDA clearance for the Air Assist™ device, a new solution to improve colonoscopy safety and efficiency.
SST, Wellcome Leap Partner to Enhance Surgical Care
By MBN Staff - Thu, 12/19/2024 - 08:30
SST and Wellcome Leap expand partnership to deploy OR Black Box technology, improving surgical care, training, and safety in seven countries.

Mexico Investigates Outbreak of Multidrug-Resistant Bacteria
By MBN Staff - Fri, 12/06/2024 - 13:08
Mexico’s Ministry of Health is investigating an outbreak of multidrug-resistant bacterial infections in hospitals and clinics in the State of Mexico.
AI Aids Housing Instability Detection, Human Oversight Essential
By Sofía Garduño - Mon, 11/25/2024 - 09:46
AI improves housing instability detection in clinical notes, but human oversight ensures accuracy and safeguards patient safety.
New Initiative to Drive Healthcare Digitization
By MBN Staff - Mon, 11/04/2024 - 09:39
The Connect to a Better Health Experience initiative seeks to digitize healthcare in Mexico, improving medical safety and efficiency,
FDA Recalls Hologic's Biozorb Markers Due to Risks
By MBN Staff - Wed, 10/30/2024 - 10:35
The FDA warns against using Hologic’s Biozorb markers following reports of serious complications, prompting a Class I recall for patient safety.

FDA Places Clinical Hold on Kezar Life Sciences' Lupus Trial
By MBN Staff - Fri, 10/11/2024 - 10:53
The FDA has halted Kezar Life Sciences' lupus nephritis trial after four patient deaths raised safety concerns, impacting zetomipzomib development.